US Stock MarketDetailed Quotes

PMCB PharmaCyte Biotech

Watchlist
  • 1.700
  • -0.050-2.86%
Close Nov 22 16:00 ET
  • 1.700
  • 0.0000.00%
Post 16:00 ET
13.05MMarket Cap2.66P/E (TTM)

PharmaCyte Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jul 31, 2024
(FY)Apr 30, 2024
(Q4)Apr 30, 2024
(Q3)Jan 31, 2024
(Q2)Oct 31, 2023
(Q1)Jul 31, 2023
(FY)Apr 30, 2023
(Q4)Apr 30, 2023
(Q3)Jan 31, 2023
(Q2)Oct 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-208.85%-373.3K
43.29%-2.15M
-15.45%-332.96K
67.31%-177.1K
-5.59%-1.98M
131.63%342.96K
7.86%-3.79M
75.80%-288.39K
-81.39%-541.7K
-35.63%-1.88M
Net income from continuing operations
835.76%23.42M
107.73%333.76K
1,165.95%1.35M
18.92%-619.54K
248.36%2.79M
-106.04%-3.18M
-1.81%-4.32M
91.12%-126.34K
5.81%-764.14K
-91.94%-1.88M
Operating gains losses
-1,269.21%-23.17M
---4.17M
---2.62M
---230K
---3.31M
--1.98M
----
----
----
----
Other non cash items
----
-212.05%-195K
----
----
----
40,007.11%913.64K
399.40%174.02K
91.21%5.88K
6,692.30%165.87K
--0
Change In working capital
-80.07%125.67K
200.58%298.89K
151.90%87.15K
123.67%135.74K
-7,954.17%-554.61K
39.82%630.62K
-3,387.23%-297.17K
-175.60%-167.93K
-215.94%-573.37K
98.41%-6.89K
-Change in prepaid assets
2.85%19.57K
-1,026.06%-152.12K
-48.23%37.96K
-66.46%25.43K
-2.57%-234.54K
-71.18%19.03K
35.80%-13.51K
-8.26%73.33K
11.97%75.8K
-392.17%-228.66K
-Change in payables and accrued expense
-82.65%106.1K
259.00%451.01K
120.39%49.19K
116.99%110.31K
-244.32%-320.07K
58.86%611.59K
-1,033.17%-283.66K
-269.66%-241.25K
-252.08%-649.17K
143.50%221.78K
Cash from discontinued investing activities
Operating cash flow
-208.85%-373.3K
43.29%-2.15M
-15.45%-332.96K
67.31%-177.1K
-5.59%-1.98M
131.63%342.96K
7.86%-3.79M
75.80%-288.39K
-81.39%-541.7K
-35.63%-1.88M
Investing cash flow
Cash flow from continuing investing activities
-7M
-5M
0
0
0
0
Net investment purchase and sale
---7M
---5M
--0
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
---7M
---5M
--0
---5M
--0
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-261.99%-10.17M
21.03%-10.71M
-148.38%-10.7M
-86.31%-7.04M
122.12%748.69K
400.44%6.28M
-115.53%-13.56M
-8,376.76%-4.31M
-3.78M
-103.87%-3.39M
Net common stock issuance
97.19%-742.18K
-107.94%-28.2M
72.73%-1.17M
89.39%-400.71K
95.13%-164.95K
-1,165.39%-26.46M
-115.52%-13.56M
-113.60%-4.31M
---3.78M
-106.08%-3.39M
Net preferred stock issuance
-126.94%-9.43M
--17.49M
---9.52M
---6.64M
---1.35M
--35M
--0
--0
--0
--0
Proceeds from stock option exercised by employees
--0
-92.05%70
--0
--0
--0
-92.05%70
--880
--0
--0
--0
Net other financing activities
----
----
----
----
----
---2.26M
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-261.99%-10.17M
21.03%-10.71M
-148.38%-10.7M
-86.31%-7.04M
122.12%748.69K
400.44%6.28M
-115.53%-13.56M
-8,376.76%-4.31M
---3.78M
-103.87%-3.39M
Net cash flow
Beginning cash position
-26.25%50.18M
-20.33%68.04M
-15.73%61.21M
-4.60%73.43M
-9.20%74.66M
-20.33%68.04M
3,778.14%85.4M
-16.16%72.64M
-11.47%76.96M
8,471.89%82.23M
Current changes in cash
-364.95%-17.55M
-2.92%-17.86M
-140.04%-11.03M
-182.79%-12.22M
76.53%-1.24M
308.61%6.62M
-120.86%-17.35M
-269.78%-4.6M
-1,346.47%-4.32M
-106.12%-5.26M
Effect of exchange rate changes
-59.42%183
92.99%-508
91.70%-438
141.90%1.07K
-120.97%-1.59K
-65.41%451
-256.67%-7.25K
-248.87%-5.28K
-1,116.19%-2.55K
-124.78%-720
End cash Position
-56.29%32.64M
-26.25%50.18M
-26.25%50.18M
-15.73%61.21M
-4.60%73.43M
-9.20%74.66M
-20.33%68.04M
-20.33%68.04M
-16.16%72.64M
-11.47%76.96M
Free cash flow
-208.85%-373.3K
43.29%-2.15M
-15.45%-332.96K
67.31%-177.1K
-5.59%-1.98M
131.63%342.96K
7.86%-3.79M
75.80%-288.39K
-81.39%-541.7K
-35.63%-1.88M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Jul 31, 2024(FY)Apr 30, 2024(Q4)Apr 30, 2024(Q3)Jan 31, 2024(Q2)Oct 31, 2023(Q1)Jul 31, 2023(FY)Apr 30, 2023(Q4)Apr 30, 2023(Q3)Jan 31, 2023(Q2)Oct 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -208.85%-373.3K43.29%-2.15M-15.45%-332.96K67.31%-177.1K-5.59%-1.98M131.63%342.96K7.86%-3.79M75.80%-288.39K-81.39%-541.7K-35.63%-1.88M
Net income from continuing operations 835.76%23.42M107.73%333.76K1,165.95%1.35M18.92%-619.54K248.36%2.79M-106.04%-3.18M-1.81%-4.32M91.12%-126.34K5.81%-764.14K-91.94%-1.88M
Operating gains losses -1,269.21%-23.17M---4.17M---2.62M---230K---3.31M--1.98M----------------
Other non cash items -----212.05%-195K------------40,007.11%913.64K399.40%174.02K91.21%5.88K6,692.30%165.87K--0
Change In working capital -80.07%125.67K200.58%298.89K151.90%87.15K123.67%135.74K-7,954.17%-554.61K39.82%630.62K-3,387.23%-297.17K-175.60%-167.93K-215.94%-573.37K98.41%-6.89K
-Change in prepaid assets 2.85%19.57K-1,026.06%-152.12K-48.23%37.96K-66.46%25.43K-2.57%-234.54K-71.18%19.03K35.80%-13.51K-8.26%73.33K11.97%75.8K-392.17%-228.66K
-Change in payables and accrued expense -82.65%106.1K259.00%451.01K120.39%49.19K116.99%110.31K-244.32%-320.07K58.86%611.59K-1,033.17%-283.66K-269.66%-241.25K-252.08%-649.17K143.50%221.78K
Cash from discontinued investing activities
Operating cash flow -208.85%-373.3K43.29%-2.15M-15.45%-332.96K67.31%-177.1K-5.59%-1.98M131.63%342.96K7.86%-3.79M75.80%-288.39K-81.39%-541.7K-35.63%-1.88M
Investing cash flow
Cash flow from continuing investing activities -7M-5M0000
Net investment purchase and sale ---7M---5M--0----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow ---7M---5M--0---5M--0--0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities -261.99%-10.17M21.03%-10.71M-148.38%-10.7M-86.31%-7.04M122.12%748.69K400.44%6.28M-115.53%-13.56M-8,376.76%-4.31M-3.78M-103.87%-3.39M
Net common stock issuance 97.19%-742.18K-107.94%-28.2M72.73%-1.17M89.39%-400.71K95.13%-164.95K-1,165.39%-26.46M-115.52%-13.56M-113.60%-4.31M---3.78M-106.08%-3.39M
Net preferred stock issuance -126.94%-9.43M--17.49M---9.52M---6.64M---1.35M--35M--0--0--0--0
Proceeds from stock option exercised by employees --0-92.05%70--0--0--0-92.05%70--880--0--0--0
Net other financing activities -----------------------2.26M----------------
Cash from discontinued financing activities
Financing cash flow -261.99%-10.17M21.03%-10.71M-148.38%-10.7M-86.31%-7.04M122.12%748.69K400.44%6.28M-115.53%-13.56M-8,376.76%-4.31M---3.78M-103.87%-3.39M
Net cash flow
Beginning cash position -26.25%50.18M-20.33%68.04M-15.73%61.21M-4.60%73.43M-9.20%74.66M-20.33%68.04M3,778.14%85.4M-16.16%72.64M-11.47%76.96M8,471.89%82.23M
Current changes in cash -364.95%-17.55M-2.92%-17.86M-140.04%-11.03M-182.79%-12.22M76.53%-1.24M308.61%6.62M-120.86%-17.35M-269.78%-4.6M-1,346.47%-4.32M-106.12%-5.26M
Effect of exchange rate changes -59.42%18392.99%-50891.70%-438141.90%1.07K-120.97%-1.59K-65.41%451-256.67%-7.25K-248.87%-5.28K-1,116.19%-2.55K-124.78%-720
End cash Position -56.29%32.64M-26.25%50.18M-26.25%50.18M-15.73%61.21M-4.60%73.43M-9.20%74.66M-20.33%68.04M-20.33%68.04M-16.16%72.64M-11.47%76.96M
Free cash flow -208.85%-373.3K43.29%-2.15M-15.45%-332.96K67.31%-177.1K-5.59%-1.98M131.63%342.96K7.86%-3.79M75.80%-288.39K-81.39%-541.7K-35.63%-1.88M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data